|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density显示文摘 | W.S Simonet D.L Lacey C.R Dunstan M Kelley M.-S Chang R Lüthy H.Q Nguyen S Wooden L Bennett T Boone G Shimamoto M DeRose R Elliott A Colombero H.-L Tan G Trail J Sullivan E Davy N Bucay L Renshaw-Gegg T.M Hughes D Hill W Pattison P Campbell S Sander G Van | 1997 | Cell1997，，2： | 6 |
| 2 | Effects of petroleum resins on asphaltene aggregation and water-in-oil emulsion formation显示文摘 | Spiecker P M Gawrys K L Trail C B | 2003 | Colloids and Surfaces A:Physicochemical and Engineering Aspects2003，220，13： | 1 |
| 3 | Clinical assessment in juvenile dermatomyositis显示文摘 | Ravelli A Ruperto N Trail L | 2006 | Autoimmunity2006，39，3： | 1 |
| 4 | Sorafenib(BAY 43-9006,Nexavar),a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature显示文摘 | Adnane L Trail PA Taylor I | 2006 | Methods Enzymol2006，407，： | 1 |
| 5 | Long - term outcome and prognostic factors of juvenile dermatomyositis: A multinational, multicenter study of 490 patients 显示文摘 | Ravelli A Trail L Ferrari C | 2010 | Arthritis care & re- search2010，62，1： | 1 |
| 6 | Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature显示文摘 | Adnane L Trail P A Taylor I | 2006 | Methods Enzymol2006，407，： | 1 |
| 7 | Sorafenib ( BAY 43 - 9006, Nexavar), a dual -action inhibitor that targets RAF/MEK/ ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature显示文摘 | ADNANE L TRAIL P A TAYLOR I | 2006 | Methods Enzymol2006，407，： | 1 |
| 8 | Effects of petroleum resins on asphaltene aggregation and water-in-oil emulsion formation显示文摘 | Spiccker P M Gawrys K L Trail C B | 2003 | Colloids and surfaces A:Physicochemical and engineering aspects2003，220，13： | 1 |
| 9 | On the origin of Darwin's finches显示文摘 | BAPTISTA L F TRAIL P W | 1988 | AUK1988，105，： | 1 |
| 10 | Sorafenib (BAY 43-9006,Nexavar),a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature显示文摘 | Adnane L Trail PA Taylor I | | 0，，： | 1 |
| 11 | Effects of petroleum resins on asphaltene aggregation and water-in-oil emulsion formation显示文摘 | P Matthew Spiecker Keith L Gawrys Chad B Trail | 2003 | Colloids and Surface- sA: Physicochem Eng Aspects2003，220，： | 1 |
| 12 | Morbidity in patients with posttransplant diabetes mellitus following orthotopic liver transplantation显示文摘 | Trail K C McCashland T M Larsen J L | 1996 | Liver Transpl Surg1996，2，： | 1 |
| 13 | Long term results of Charmley low friction arthroplasty in young patients显示文摘 | Joshi A B Porter M L Trail T A | 1993 | J Bone Joint Surg Br1993，75，4： | 1 |
| 14 | European evidence based consensus on the diagnosis and management of Crohn's disease:current management显示文摘 | Trails SP Stange EF L mann M | 2006 | Gut2006，55，1： | 1 |
| 15 | Sorafenib (BAY 43-9006,Nexavar),a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature显示文摘 | Adnane L Trail PA Taylor I | | 0，，： | 1 |
| 16 | Effects of petroleum resins on asphaltene aggregation and water-in-oil emulsion formation显示文摘 | Gawrys K L Trail C B | 2003 | Colloids and surfaces A:physicochemical and engineering aspects2003，220，13： | 1 |
| 17 | Long-term out?come and prognostic factors of juvenile dermatomyosi?tis: a multinational, multicenter study of 490 patients显示文摘 | Ravelli A Trail L Ferrari C et a1 | 2010 | Arthritis Care Res (Hoboken)2010，62，1： | 1 |
| 18 | Clinical assessment in juvenile dermatomyositis显示文摘 | Ravelli A Ruperto N Trail L | 2006 | Autoimmunity2006，39，3： | 1 |
| 19 | 查看详情显示文摘 | Spiecker P M Gawrys K L Trail C B | | 0，，： | 1 |
| 20 | Effects of petroleum resins on asphaltene aggregation and water-in-oil emulsion formation显示文摘 | Gawrys K L Trail C B | 2003 | Colloids and Surfaces A:Physicochemical and Engineering Aspects2003，220，123： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员